Jane Singleton, MBA, is a business leader recognized for their expertise in global asset launches and strategic development within the immuno-dermatology sector at UCB. They have led multiple global workstreams, ensuring successful launches of innovative medicines. Previously, they held significant roles at Eli Lilly and Company, focusing on business development and market access, alongside managerial positions in conference directing and healthcare representation at various organizations. Jane is currently pursuing a B.Sc (Hons) in Anatomy & Physiology at the University of Leeds, building on an executive MBA from Henley Business School and a postgraduate certificate in Health Economics from the University of Aberdeen.
This person is not in the org chart
This person is not in any teams
This person is not in any offices